We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Standards, Options: Recommandations pour I’indication des agents stimulant l’érythropoïèse (ASE: époétine alpha, époétine bêta et darbépoétine) dans la prise en charge de l’anémie en cancérologie (mise à jour 2007), rapport abrégé
- Authors
Ray-Coquard, I.; Kassab-Chahmi, D.; Casadevall, N.; Chastagner, P.; Marchal, C.; Marec-Bérard, P.; Misset, J.-L.; Alibeu, J.-P.; Lauwers, E. A.; Balp, L.; Bergerat, J.-P.; Blay, J.-Y.; Camerlo, J.; Cheze, S.; Colombat, P.; Coudert, B.; Dabouis, G.; Daouphars, M.; Debourdeau, P.; Di Palma, M.
- Abstract
Since 1998, a working group of specialists set up by the guidelines department (Standards, Options and Recommendations: SOR) from the National French Federation of Comprehensive Cancer Centres (FNCLCC) published then updated regularly recommendations relative to the use of ESA in anaemic patients with cancer. The systematic monitoring process realized in 2006 has permitted the identification of new data non concordant with the last actualization of 2003, conferring thus sufficient indices to consider modifications in the existing recommendations. This work was performed in collaboration with specialists from university or general hospitals and private clinics, and with the French National Cancer Institute. This article presents a short version of the updated 2007 recommendations. This updating process is based on the methodology developed and used in the “Standards, Options, Recommendations” programme. The methodological approach combines systematic review with multidisciplinary group of experts’ judgement....
- Subjects
ERYTHROPOIESIS; HEMATOPOIESIS; ANEMIA; BLOOD diseases; CANCER patients; TUMORS; PATIENTS
- Publication
Oncologie (Tech Science Press), 2008, Vol 10, Issue 2, p160
- ISSN
1292-3818
- Publication type
Article
- DOI
10.1007/s10269-008-0832-4